Wang, Liang <br/><br/>
Basing on uPAR-binding fragment to design chimeric antigen receptors triggers antitumor efficacy against uPAR expressing ovarian cancer cells.  [electronic resource] 

 -  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  Sep 2019 
 - 109173 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1950-6007 
<br/><br/><label>Standard No.: </label>10.1016/j.biopha.2019.109173  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--pharmacology<br/>Cell Line<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Female<br/>HEK293 Cells<br/>Humans<br/>Immunotherapy--methods<br/>Membrane Proteins--metabolism<br/>Middle Aged<br/>Neoplasm Metastasis--drug therapy<br/>Ovarian Neoplasms--drug therapy<br/>Receptors, Chimeric Antigen--metabolism<br/>Up-Regulation--drug effects<br/>Young Adult